Skip to content

Commit de6610f

Browse files
committed
Add published-202605-bangard-adverse to published.yml
Article was previously skipped because quarto inspect failed due to: - Trailing period in error message not stripped - Full temp path not converted to repo-relative path Fixed in PublicationUpdater parseMissingFileFromError function.
1 parent a1be5e3 commit de6610f

1 file changed

Lines changed: 86 additions & 0 deletions

File tree

‎site/published.yml‎

Lines changed: 86 additions & 0 deletions
Original file line numberDiff line numberDiff line change
@@ -59,6 +59,92 @@
5959
pdf: ''
6060
url: https://computo-journal.org/published-202606-devijver-scb/
6161
status: published
62+
- title: Detecting adverse high-order drug combinations from individual case safety reports using computational statistics on disproportionality measures
63+
name: published-202605-bangard-adverse
64+
authors: Jules Bangard, Einar Holsbø, Kristian Svendsen, Vittorio Perduca and Étienne Birmelé
65+
journal: Computo
66+
doi: 10.57750/7e54-2z98
67+
year: 2026
68+
date: 2026-07-15
69+
description: >
70+
Adverse drug combination detection using individual case safety reports
71+
abstract: >-
72+
Adverse drug reactions linked to the intake of drug
73+
combinations are a critical concern in pharmacovigilance,
74+
particularly as the controlled environment of clinical trials often
75+
lacks the scale and diversity to detect rare events involving
76+
multiple medications. While spontaneous reporting systems provide
77+
the necessary breadth for post-market surveillance, identifying
78+
overrepresented drug cocktails within such large-scale data remains
79+
a significant computational challenge. This study introduces a
80+
computational framework for the detection of drug cocktails
81+
associated with adverse events, leveraging disproportionality
82+
analysis on individual case safety reports. By integrating the
83+
Anatomical Therapeutic Chemical classification, the framework
84+
extends beyond individual drugs to capture hierarchical
85+
pharmacological relationships, enabling exploration of the space of
86+
drug combinations beyond pairwise analysis. To address biases
87+
inherent in existing disproportionality measures, we employ a
88+
hypergeometric risk metric, while a Markov Chain Monte Carlo
89+
algorithm provides robust empirical p-value estimation for the risk
90+
associated with cocktails. A genetic algorithm further facilitates
91+
efficient identification of high-risk drug cocktails. A
92+
post-treatment step based on penalized logistic regression allows
93+
distinguishing true pharmacological interactions from combined
94+
individual effects for cocktails of any size. Validation on
95+
synthetic and FDA Adverse Event Reporting System data demonstrates
96+
the method’s efficacy in detecting established drugs and drug
97+
combinations associated with myopathy-related adverse events.
98+
Implemented as an R package, this framework offers a reproducible,
99+
scalable tool for post-market drug safety surveillance.
100+
repo: published-202605-bangard-adverse
101+
bibtex: >+
102+
@article{bangard2026,
103+
author = {Bangard, Jules and Holsbø, Einar and Svendsen, Kristian and
104+
Perduca, Vittorio and Birmelé, Étienne},
105+
publisher = {French Statistical Society},
106+
title = {Detecting Adverse High-Order Drug Combinations from
107+
Individual Case Safety Reports Using Computational Statistics on
108+
Disproportionality Measures},
109+
journal = {Computo},
110+
date = {2026-07-15},
111+
url = {https://computo-journal.org/published-202605-bangard-adverse/},
112+
doi = {10.57750/7e54-2z98},
113+
issn = {2824-7795},
114+
langid = {en},
115+
abstract = {Adverse drug reactions linked to the intake of drug
116+
combinations are a critical concern in pharmacovigilance,
117+
particularly as the controlled environment of clinical trials often
118+
lacks the scale and diversity to detect rare events involving
119+
multiple medications. While spontaneous reporting systems provide
120+
the necessary breadth for post-market surveillance, identifying
121+
overrepresented drug cocktails within such large-scale data remains
122+
a significant computational challenge. This study introduces a
123+
computational framework for the detection of drug cocktails
124+
associated with adverse events, leveraging disproportionality
125+
analysis on individual case safety reports. By integrating the
126+
Anatomical Therapeutic Chemical classification, the framework
127+
extends beyond individual drugs to capture hierarchical
128+
pharmacological relationships, enabling exploration of the space of
129+
drug combinations beyond pairwise analysis. To address biases
130+
inherent in existing disproportionality measures, we employ a
131+
hypergeometric risk metric, while a Markov Chain Monte Carlo
132+
algorithm provides robust empirical p-value estimation for the risk
133+
associated with cocktails. A genetic algorithm further facilitates
134+
efficient identification of high-risk drug cocktails. A
135+
post-treatment step based on penalized logistic regression allows
136+
distinguishing true pharmacological interactions from combined
137+
individual effects for cocktails of any size. Validation on
138+
synthetic and FDA Adverse Event Reporting System data demonstrates
139+
the method’s efficacy in detecting established drugs and drug
140+
combinations associated with myopathy-related adverse events.
141+
Implemented as an R package, this framework offers a reproducible,
142+
scalable tool for post-market drug safety surveillance.}
143+
}
144+
145+
pdf: ''
146+
url: https://computo-journal.org/published-202605-bangard-adverse/
147+
status: published
62148
- title: Variational inference for approximate objective priors using neural networks
63149
name: published-202512-baillie-varp
64150
authors: Nils Baillie, Antoine Van Biesbroeck and Clément Gauchy

0 commit comments

Comments
 (0)